ResMed, Inc. (RMD)
242.85
-1.91
(-0.78%)
USD |
NYSE |
Dec 29, 16:00
241.90
-0.95
(-0.39%)
Pre-Market: 20:00
ResMed EPS Diluted (Quarterly): 2.373 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Boston Scientific Corp. | 0.5048 |
| Abbott Laboratories | 0.9146 |
| Stryker Corp. | 2.221 |
| Becton, Dickinson & Co. | 1.717 |
| West Pharmaceutical Services, Inc. | 1.928 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 348.54M |
| Revenue (Quarterly) | 1.336B |
| Total Expenses (Quarterly) | 987.05M |
| Enterprise Value | 34.90B |
| Gross Profit Margin (Quarterly) | 60.56% |
| Profit Margin (Quarterly) | 26.10% |
| Earnings Yield | 4.02% |
| Operating Earnings Yield | 4.93% |
| Normalized Earnings Yield | 4.038 |